- Country: Russia
- Summary: Medicines: Betagistin, Bupivacaine, Vanimicin, Water for Injection, Water for Injection, Haloperidol, Iron [Iii] Hydroxide Sucrose Complex, Sodium Chloride, ...
- RUT Ref No: 114968626
- Deadline: 25 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 460250.51
- Notice Type: Tender
- Document Ref. No.: 0320300029825000013
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Medicines: Betagistin, bupivakain, vanimicin, water for injection, water for injection, haloperidol, iron [III] hydroxide sucrose complex, sodium chloride, sivofluraran, thizanine for medical use
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines: Betagistin, Bupivacaine, Vanimicin, Water for Injection, Water for Injection, Haloperidol, Iron [Iii] Hydroxide Sucrose Complex, Sodium Chloride, ... - Russia Tender
The REGIONAL STATE BUDGETARY INSTITUTION OF HEALTH "HASSAN CENTRAL DISTRICT HOSPITAL, a Government sector organization in Russia, has announced a new tender for Medicines: Betagistin, Bupivacaine, Vanimicin, Water for Injection, Water for Injection, Haloperidol, Iron [Iii] Hydroxide Sucrose Complex, Sodium Chloride, .... This tender is published on RussiaTenders under RUT Ref No: 114968626 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-25.
The estimated tender value is 460250.51, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
